Trial Profile
Phase III study of CIDECIN in patients with endocarditis caused by S. aureus
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary)
- Indications Bacterial endocarditis
- Focus Therapeutic Use
- 16 Jun 2016 New trial record